All In Biotech

Drug Trial Radar · NCT02812771

Safety and Pharmacokinetics of Efinaconazole Topical Solution in Subjects With Mild to Severe Onychomycosis

A Multicenter, Open Label, Single-arm Study Evaluating the Safety and Pharmacokinetics of Efinaconazole Topical Solution in Subjects With Mild to Severe Onychomycosis of the Toenails

Last checked: Nov 20, 2026Latest source record: Nov 1, 2021 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registry

Status

Completed

Enrollment

62

Actual

Start

Aug 4, 2016

Primary completion

Jan 14, 2019

Study completion Jan 14, 2019

Sponsor

Lead sponsor
Bausch Health Americas, Inc.Industry
Sponsor type
Industry
First posted
Jun 24, 2016

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 4
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
Who can join
All sexes, from 6 years, up to 16 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

Safety and Pharmacokinetics (PK) of a once daily topical application of efinaconazole in the treatment of pediatric subjects with mild to severe onychomycosis of the toenails.

Conditions

  • Onychomycosis

Interventions

  • EfinaconazoleDrug

    Solution

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Percentage of Participants With at Least One Adverse EventTime frame: 48 weeks

Locations

10 sites in 2 countries. Site status is shown where the registry gives one.

  • Valeant Site 01

    Birmingham, Alabama

  • Valeant Site 04

    Fountain Valley, California

  • Valeant Site 03

    Santa Rosa, California

  • Valeant SIte 05

    South Miami, Florida

  • Valeant Site 09

    New Orleans, Louisiana

  • Valeant Site 08

    Baltimore, Maryland

  • Valeant Site 02

    Forest Hills, New York

  • Valeant Site 06

    Philadelphia, Pennsylvania

  • Valeant Site 07

    McAllen, Texas

  • Valeant Site 10

    Santo Domingo, Dominican Republic

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.